Featured Research

from universities, journals, and other organizations

Study Of New Treatment For Short Stature Underway At Rush University Medical Center

Date:
September 20, 2005
Source:
Rush University Medical Center
Summary:
Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure. The drug, called Increlex, was approved by the FDA August 31 for the most severe form of short stature due to a deficiency of Insulin-like Growth Factor-1 (IGF-1). Ongoing trials will determine if the drug may be used for less severe growth disease.

CHICAGO -- Rush University Medical Center is participating ina clinical trial to evaluate the potential benefit of the first majorinnovation in 20 years for the treatment of growth failure. The drug,called Increlex, was approved by the FDA August 31 for the most severeform of short stature due to a deficiency of Insulin-like GrowthFactor-1 (IGF-1). Ongoing trials will determine if the drug may be usedfor less severe growth disease.

Insulin-like Growth Factor-1(IGF-1) is the proximate hormone necessary for statural growth and mustbe present in order for children's bones, cartilage and organs to grownormally. In healthy individuals, growth hormone is secreted into thebloodstream by the pituitary gland and binds to growth hormonereceptors on liver and other cells, where it stimulates the cellularproduction and secretion of IGF-1 into the bloodstream.

"Fordecades, the only available drug treatment for short stature has beenshots of growth hormone. However, patients who are deficient in IGF-1and resistant to the effects of growth hormone do not respond well, ifat all, to the shots," said Dr. Richard Levy, a pediatricendocrinologist at Rush. "Instead of using growth hormone to stimulatethe production of IGF-1, the goal is to replace the IGF-1 directly."

Increlexis a genetically engineered copy of IGF-1. The purified protein hasbeen shown to be structurally and functionally identical to naturalhuman IGF-1. It is injected daily before a meal to provide the catalystthe body needs to grow.

The FDA's approval of Increlex is basedon clinical trial data from 71 patients. Data reported at the 2004Annual Meeting of the Endocrine Society demonstrated a statisticallysignificant increase in growth rate over an eight-year period inresponse to Increlex therapy. Compared to pre-treatment growthpatterns, on average, children gained an additional inch per year foreach year of therapy over the course of eight years. In addition, ananalysis of safety in the study concluded that long-term treatmentappears to be well tolerated and has an acceptable safety profile. Themost common adverse events were hypoglycemia, lipohypertrophy andtonsillar hypertrophy.

Primary IGFD afflicts an estimated 30,000children evaluated for short stature in the United States. A child withshort stature is defined as being shorter than 97.5 percent of allchildren the same age and gender. If untreated, Primary IGFD may lead,in children and adults, to a range of other metabolic disorders,including lipid abnormalities, decreased bone density, obesity, andinsulin resistance.

Increlex is manufactured by Tercica, Inc., abiopharmaceutical company focused on the development andcommercialization of products to improve endocrine health. For furtherinformation on Tercica please visit www.tercica.com.

For more information about Pediatric Endocrinology services at Rush, please call Dr. Levy's office at 312-942-8989.


Story Source:

The above story is based on materials provided by Rush University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Rush University Medical Center. "Study Of New Treatment For Short Stature Underway At Rush University Medical Center." ScienceDaily. ScienceDaily, 20 September 2005. <www.sciencedaily.com/releases/2005/09/050920081239.htm>.
Rush University Medical Center. (2005, September 20). Study Of New Treatment For Short Stature Underway At Rush University Medical Center. ScienceDaily. Retrieved July 28, 2014 from www.sciencedaily.com/releases/2005/09/050920081239.htm
Rush University Medical Center. "Study Of New Treatment For Short Stature Underway At Rush University Medical Center." ScienceDaily. www.sciencedaily.com/releases/2005/09/050920081239.htm (accessed July 28, 2014).

Share This




More Health & Medicine News

Monday, July 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com
West Africa Gripped by Deadly Ebola Outbreak

West Africa Gripped by Deadly Ebola Outbreak

AFP (July 28, 2014) The worst-ever outbreak of the deadly Ebola epidemic grips west Africa, killing hundreds. Duration: 00:48 Video provided by AFP
Powered by NewsLook.com
Trees Could Save More Than 850 Lives Each Year

Trees Could Save More Than 850 Lives Each Year

Newsy (July 27, 2014) A national study conducted by the USDA Forest Service found that trees collectively save more than 850 lives on an annual basis. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins